Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lewandowski

Showing results (81-90 of 234) with videos related to

Pageof 24
Sort By:
Annals of the Rheumatic Diseases|January 15, 2026
Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approachHeather Cross, Junjie Peng, Thomas McDonnell, et al.
Genes and Immunity|July 24, 2023
Transmission disequilibrium analysis of whole genome data in childhood-onset systemic lupus erythematosusKathleen M Vazzana, Anthony M Musolf, Joan E Bailey-Wilson, et al.
Annals of the Rheumatic Diseases|September 5, 2024
Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis <i>et al</i>Jordan Elizabeth Roberts, Nayimisha Balmuri, Joyce C Chang, et al.
Lupus|July 5, 2021
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohortKathleen M Vazzana, Ankana Daga, Beatrice Goilav, et al.
ACR Open Rheumatology|November 26, 2025
Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus NephritisChristine S Wang, Rebecca E Sadun, Wenru Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2023
Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus NephritisChristine S Wang, Rebecca E Sadun, Wenru Zhou, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2010
Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategiesAssaf Anyamba, Kenneth J Linthicum, Jennifer Small, et al.
Annals of the Rheumatic Diseases|January 10, 2023
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task forceEve Mary Dorothy Smith, Amita Aggarwal, Jenny Ainsworth, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
GWAS identifies genetic loci for antibody response to SARS-CoV-2 vaccines in patients with systemic autoimmune diseases and healthy individualsKwangwoo Kim, Dillon Claybaugh, Eduardo Patino-Martinez, et al.
The Journal of Rheumatology|February 1, 2026
Genome-Wide Association Study Identifies Genetic Loci for Antibody Response to SARS-CoV-2 Vaccines in Patients With Systemic Autoimmune Diseases and Healthy IndividualsKwangwoo Kim, Dillon Claybaugh, Eduardo Patino-Martinez, et al.
Pageof 24

Showing results (81-90 of 234) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|January 15, 2026
Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approachHeather Cross, Junjie Peng, Thomas McDonnell, et al.
Genes and Immunity|July 24, 2023
Transmission disequilibrium analysis of whole genome data in childhood-onset systemic lupus erythematosusKathleen M Vazzana, Anthony M Musolf, Joan E Bailey-Wilson, et al.
Annals of the Rheumatic Diseases|September 5, 2024
Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis <i>et al</i>Jordan Elizabeth Roberts, Nayimisha Balmuri, Joyce C Chang, et al.
Lupus|July 5, 2021
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohortKathleen M Vazzana, Ankana Daga, Beatrice Goilav, et al.
ACR Open Rheumatology|November 26, 2025
Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus NephritisChristine S Wang, Rebecca E Sadun, Wenru Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2023
Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus NephritisChristine S Wang, Rebecca E Sadun, Wenru Zhou, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2010
Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategiesAssaf Anyamba, Kenneth J Linthicum, Jennifer Small, et al.
Annals of the Rheumatic Diseases|January 10, 2023
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task forceEve Mary Dorothy Smith, Amita Aggarwal, Jenny Ainsworth, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
GWAS identifies genetic loci for antibody response to SARS-CoV-2 vaccines in patients with systemic autoimmune diseases and healthy individualsKwangwoo Kim, Dillon Claybaugh, Eduardo Patino-Martinez, et al.
The Journal of Rheumatology|February 1, 2026
Genome-Wide Association Study Identifies Genetic Loci for Antibody Response to SARS-CoV-2 Vaccines in Patients With Systemic Autoimmune Diseases and Healthy IndividualsKwangwoo Kim, Dillon Claybaugh, Eduardo Patino-Martinez, et al.
Pageof 24